Xu CB - Search Results

1

Methyl chanofruticosinate type alkaloids from the aerial parts of Kopsia lancibracteolata Merr.

Wang JF, Wang Y, Wang HL, Xu CB, Wang HT. Wang JF, et al. Among authors: xu cb. J Asian Nat Prod Res. 2019 Mar;21(3):227-233. doi: 10.1080/10286020.2017.1418860. Epub 2018 Jan 3. J Asian Nat Prod Res. 2019. PMID: 29295627

2

CDX2 enhances natural killer cell-mediated immunotherapy against head and neck squamous cell carcinoma through up-regulating CXCL14.

Wang H, Nan S, Wang Y, Xu C. Wang H, et al. J Cell Mol Med. 2021 May;25(10):4596-4607. doi: 10.1111/jcmm.16253. Epub 2021 Mar 17. J Cell Mol Med. 2021. PMID: 33733587 Free PMC article.

3

Serum Interleukin-37 Increases in Patients after Ischemic Stroke and Is Associated with Stroke Recurrence.

Zhang Y, Xu C, Wang H, Nan S. Zhang Y, et al. Oxid Med Cell Longev. 2021 Apr 13;2021:5546991. doi: 10.1155/2021/5546991. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33953828 Free PMC article.

4

Interfering microRNA-410 attenuates atherosclerosis via the HDAC1/KLF5/IKBα/NF-κB axis.

Nan S, Wang Y, Xu C, Wang H. Nan S, et al. Mol Ther Nucleic Acids. 2021 Mar 13;24:646-657. doi: 10.1016/j.omtn.2021.03.009. eCollection 2021 Jun 4. Mol Ther Nucleic Acids. 2021. PMID: 33981482 Free PMC article.

5

Mechanisms correlated with chemotherapy resistance in tongue cancers.

Han G, Xu C, Yu D. Han G, et al. J Cancer Res Ther. 2018 Jan;14(1):1-5. doi: 10.4103/jcrt.JCRT_763_17. J Cancer Res Ther. 2018. PMID: 29516950 Free article. Review.

6

Granulomatosis with polyangiitis accompanied by manifestations of ovarian and cervical lesions.

Nan SJ, Li WY, Xu CB, Song CL. Nan SJ, et al. Among authors: xu cb. Am J Med Sci. 2014 Oct;348(4):352-3. doi: 10.1097/MAJ.0000000000000322. Am J Med Sci. 2014. PMID: 25163020 No abstract available.

7

microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.

Xu CB, Liu XS, Li JQ, Zhao X, Xin D, Yu D. Xu CB, et al. J Cell Biochem. 2019 Jun;120(6):10830-10846. doi: 10.1002/jcb.28374. Epub 2019 Jan 31. J Cell Biochem. 2019. Retraction in: J Cell Biochem. 2021 Nov;122 Suppl 1:S126. doi: 10.1002/jcb.30106 PMID: 30706537 Retracted.

8

Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.

Xue K, Cao J, Wang Y, Zhao X, Yu D, Jin C, Xu C. Xue K, et al. Clin Transl Sci. 2020 Mar;13(2):265-274. doi: 10.1111/cts.12690. Epub 2019 Dec 21. Clin Transl Sci. 2020. PMID: 31863646 Free PMC article.

9

Identification of genes associated with tongue cancer in patients with a history of tobacco and/or alcohol use.

Zhao Y, Fu D, Xu C, Yang J, Wang Z. Zhao Y, et al. Oncol Lett. 2017 Feb;13(2):629-638. doi: 10.3892/ol.2016.5497. Epub 2016 Dec 14. Oncol Lett. 2017. PMID: 28356939 Free PMC article.

10

Expression of Programmed Death-Ligand 1 in Laryngeal Carcinoma and its Effects on Immune Cell Subgroup Infiltration.

Yu D, Cheng J, Xue K, Zhao X, Wen L, Xu C. Yu D, et al. Pathol Oncol Res. 2019 Oct;25(4):1437-1443. doi: 10.1007/s12253-018-0501-x. Epub 2018 Oct 25. Pathol Oncol Res. 2019. PMID: 30361911 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters